FK LABORATORIZ
FK Laboratoriz has developed a drug which is a new structure of a highly specific direct thrombin inhibitor. Its expected pharmacological effects correspond to those stipulated by international standards and enable the product to compete with other medicinal products available at the EEU market. The drug was developed with the use of a combination of computer-based simulation and chemosynthesis, which are modern and recognized methods applied in the pharmaceutical industry.
FK LABORATORIZ
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Status:
Active
Total Funding:
174 K USD
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Laccure AB
Laccure AB has developed a groundbreaking product for easier treatment and prevention of bacterial vaginos (BV).
Investors List
DI Group
DI Group investment in Seed Round - FK Laboratoriz
Primer Capital
Primer Capital investment in Seed Round - FK Laboratoriz
More informations about "FK Laboratoriz"
FK Laboratoriz Company Profile 2024: Valuation, Funding
FK Laboratoriz General Information Description. Developer of a novel drug designed for the treatment and prevention of thrombosis. The company's drug is a kind of direct thrombi …See details»
FK Laboratoriz - Headquarter Location, Corporate Office Address …
FK Laboratoriz is Drug Discovery in Russia that focus on chemical synthesis business. Founded in 2015. They cover business area such as developer, a novel drug, prevention, thrombosis, a …See details»
FK Laboratoriz - VentureRadar
FK Laboratoriz is developing a medication for treatment and prevention of thrombosis. FK Laboratoriz has developed a drug which is a new structure of a highly specific direct thrombin …See details»
FK Laboratoriz OOO - Drug pipelines, Patents, Clinical trials
Last update 01 Nov 2024. FK Laboratoriz OOO. Private Company |See details»
FK Laboratoriz - Crunchbase
FK Laboratoriz is develops and markets drug for the treatment and prevention of thrombosis.See details»
Russian Company OOO "FK LABORATORIZ" - ReadyRatios
Jun 27, 2023 The organization OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "FK LABORATORIZ" was registered in the Unified State Register of Legal Entities 7 years 8 …See details»
FK Laboratoriz Asset Profile | Preqin
Based in Moscow, Russia, FK Laboratoriz is a pharmaceutical company that focuses on developing a drug for the treatment and prevention of thrombosis. Current Investors Primer …See details»
Seed Round - FK Laboratoriz - 2016-10-01 - Crunchbase
Organization Name . FK Laboratoriz . Announced Date Oct 1, 2016; Funding Type ...See details»
FK Laboratories - Products, Competitors, Financials, Employees ...
2 Nov '16 announced its $175,000 investment in FK Laboratories, the domestic developer of a novel drug candidate to prevent and treat thromboses. Thrombosis is the formation of solid …See details»
Similar companies to FK Laboratoriz | VentureRadar
FK Laboratoriz profile. Similar Companies to FK Laboratoriz. Export Dansk Biotek. n/a. Founded 2010. Unknown. DANISH BIOTECH is a trade organization for Danish biotech companies with …See details»
Russian company develops advanced thrombosis therapy
Feb 10, 2017 FK Laboratories, a domestic biotech developer, is working on its novel drug candidate to prevent and treat thromboses, a serious health condition for millions of people. …See details»
FK Laboratories Stock Price, Funding, Valuation, Revenue
See FK Laboratories funding rounds, investors, investments, exits and more. Evaluate their financials based on FK Laboratories's post-money valuation and revenue.See details»
Fresenius Kabi Global Website
A global player in the world of healthcare: Fresenius Kabi! Learn more about our different expertise fields responsibilites career opportunitiesSee details»
FK Laboratories - CB Insights
Explore {FK Laboratories's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. FK Laboratories CEO, …See details»
Oxford Emergent Tuberculosis Consortium Ltd. - Crunchbase
Oxford Emergent Tuberculosis Consortium Ltd. develops advanced vaccine for the prevention of tuberculosis.See details»
In-Common Laboratories - HealthMatters.io
In-Common Laboratories (ICL) is a distinctive, non-profit entity that plays a crucial role in the Canadian healthcare landscape. Established to bridge gaps between medical laboratories, …See details»
DI Group - Funding, Financials, Valuation & Investors - Crunchbase
Which industries has this organization most actively invested in? Show . Announced Date . Organization Name . Lead Investor . Funding Round . Money Raised . Oct 15, 2016: TimeFlip …See details»
Fibrose kystique Canada
Fondé en 1960, Fibrose kystique Canada est un organisme de bienfaisance national sans but lucratif qui compte parmi les trois principaux organismes caritatifs engagés dans la recherche …See details»
Laccure AB - Crunchbase
Laccure AB has developed a groundbreaking product for easier treatment and prevention of bacterial vaginos (BV).See details»